Jan Börgermann und Alk2 - Info zur Person

(1 - 5 von 8

)

Constitutively Active ALK2 Receptor Mutants Require Type II...

www.tandfonline.com

Jan Börgermann b Freie Universität Berlin and Charité, Institut für Chemie und Biochemie, and Berlin-Brandenburg School of Regenerative Therapies, Berlin, Germany Carol S. C. Lai a Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Constitutively active ALK2 receptor mutants require type II receptor...

www.wikidata.org

scientific article published on 09 April 2013

Constitutively active ALK2 receptor mutants require type II ...National Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von J Bagarova · · Zitiert von: 98 — Jana Bagarova , Ashley J Vonner, Kelli A Armstrong, Jan Börgermann, Carol S C Lai, Donna Y Deng, Hideyuki Beppu, Ivan Alfano, Panagis Filippakopoulos, ... von J Bagarova · · Zitiert von: 98 — Jana Bagarova , Ashley J Vonner, Kelli A Armstrong, Jan Börgermann, Carol S C Lai, Donna Y Deng, Hideyuki Beppu, Ivan Alfano, Panagis Filippakopoulos, ...

Constitutively Active ALK2 Receptor Mutants Require...Research Solutions/Reprints Desk

articles.researchsolutions.com

Jana Bagarova · Ashley J. Vonner · Kelli A. Armstrong · Jan Börgermann · Carol S. C. Lai · Donna Y. Deng · Hideyuki Beppu · Ivan Alfano ... Jana Bagarova · Ashley J. Vonner · Kelli A. Armstrong · Jan Börgermann · Carol S. C. Lai · Donna Y. Deng · Hideyuki Beppu · Ivan Alfano ...